Veterinary Medicine Information website

MIXOHEMOVIROVAC

Authorised
  • Myxoma virus, strain V-MXO-82, Live
  • Rabbit haemorrhagic disease virus, type 1, strain VSHI-CN 6, Inactivated
Download as PDF

Product identification

Medicine name:
MIXOHEMOVIROVAC
Active substance:
  • Myxoma virus, strain V-MXO-82, Live
  • Rabbit haemorrhagic disease virus, type 1, strain VSHI-CN 6, Inactivated
Target species:
  • Rabbit
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Myxoma virus, strain V-MXO-82, Live
    3.00
    log10 50% cell culture infectious dose
    /
    0.50
    millilitre(s)
  • Rabbit haemorrhagic disease virus, type 1, strain VSHI-CN 6, Inactivated
    6.00
    haemagglutination inhibiting unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Rabbit
      • Meat
        0
        day
  • Intramuscular use
    • Rabbit
      • Meat
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AA01
  • QI08AD02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Romvac Company S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Romvac Company S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 100146
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 4/11/2021
Download